LGC acquires The Native Antigen Company
Strengthening LGC'S offer to the IVD sector
10-Jul-2020 -
LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies.
NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a ...
acquisitions
antibodies
antigens
+3